Stanley Druckenmiller
NUVB icon

Stanley Druckenmiller’s Nuvation Bio NUVB Stock Holding History

Stanley Druckenmiller’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Hold
4,539,800
– – 0.49% 41
2026
Q1 		$19.5M Buy
+4,539,800
New +$25.3M 0.58% 40

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stanley Druckenmiller's NUVB Position: Q2 2026 in Review

Stanley Druckenmiller held its Nuvation Bio (NUVB) position steady in Q2 2026 at 4,539,800 shares worth $25.8M. The position accounts for 0.49% of the portfolio, ranked #41.

Stanley Druckenmiller first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Stanley Druckenmiller held 4,539,800 shares of Nuvation Bio worth $25.8M as of Q2 2026.
  • Stanley Druckenmiller left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.49% of Stanley Druckenmiller's portfolio in Q2 2026, its #41 holding.
  • Stanley Druckenmiller first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Duquesne Family Office's 13F filing for Q2 2026, filed 14 Aug 2026.